Parker Waichman LLP

Proton Pump Inhibitor MDL Approved to go Forward in New Jersey

Proton Pump Inhibitor MDL. The Judicial Panel on Multidistrict Litigation (JPML) has entered an order consolidating the Proton Pump Inhibitor (PPI) MDL (multidistrict litigation) on August 2, 2017. The MDL was assigned to Judge Claire C. Cecchi, U.S. District Court of New Jersey, based on the July 27, 2017 consolidation hearings at the Los Angeles […]

Proton Pump Inhibitor MDL Approved to go Forward in NJ

Proton Pump Inhibitor MDL. The Judicial Panel on Multidistrict Litigation (JPML) has entered an order consolidating the Proton Pump Inhibitor (PPI) MDL (multidistrict litigation) on August 2, 2017. The MDL was assigned to Judge Claire C. Cecchi, U.S. District Court of New Jersey, based on the July 27, 2017 consolidation hearings at the Los Angeles Federal Courthouse.

The drugs in question include Prilosec, Nexium, Protonix, and Dexlant, as well as potential numerous generic manufacturers. The hearing order has over 163 cases in 28 federal district courts and a decision will probably come in mid-August. However, the judges may attempt to come up with ways to split up the cases into structures that might be simpler and more manageable or combine all parties. Suggestions included single-product or single-defendant MDLs, separating out prescription-only users, or separating out patients who had only used products made and sold by AstraZeneca, which is currently named in 100 cases.

PPI Products Liability Litigation

The Proton-Pump Inhibitor Products Liability Litigation is where the case filing substantially increased since the initial JPML hearing on January 26, 2017 in Miami when U.S. District Judge Sarah Vance said at one point during the oral arguments “It just seems to me to be nightmarishly complex” as the primary defense counsel raised concern over the generic makers and raised concern over the generic makers and related defense issues with so many co-defendants. The JPML eventually denied the MDL 10 days later to the view that consolidation would be too cumbersome, however due to the large number of new lawsuits and the refiling of a Motion to Consolidate, the July 27th Los Angeles Hearings have had a different outcome.

An MDL is created to consolidate cases with similar complaints to be tried in one court before one judge to streamline the process, allowing a faster outcome, lower court costs, and is generally more efficient.

National law firm Parker Waichman LLP has extensive experience and success representing clients in drug injury litigation. Our lawyers are actively reviewing potential lawsuits on behalf of individuals and are available to answer questions for anyone seeking information for a potential lawsuit.

FDA and Kidney Damage Warning

FDA Adds Kidney Damage Warning Thanks To Public Citizen

 

Kidney injuries including acute interstitial nephritis (a kidney disorder that happens when the kidneys are unable to filter waste and fluid properly), chronic kidney disease, and end-stage renal disease have been named by plaintiffs as potential dangers of PPI use. In 2011, concerns that these medications have harmful side effects for users’ kidneys were brought to the U.S. Food and Drug Administration (FDA) by consumer advocacy group Public Citizen. As a result, the agency required warnings about risks of acute interstitial nephritis on labels in 2014, according to the patients’ MDL brief.

 

Scientific Study Confirming Adverse Side Effects

Recent studies have found that the use of proton pump inhibitors significantly increased the risk of kidney problems. Both Nexium and Prilosec, two of the most popular medications for indigestion and heart burn, have been associated with kidney problems.

One of the most noteworthy studies was published in the Journal of the American Society of Nephrology which found that proton pump inhibitors had a higher risk of kidney problems compared to other heart burn medications.

The study revealed a 96 percent increased risk of kidney failure when patients took PPIs, along with a 28 percent increased risk of chronic kidney disease. The risk when compared with H2 receptor blockers was comparatively higher.

In January 2016, a scientific study published recent research on independent findings of a connection between PPI use that was linked to a 20 to 50 percent higher risk of chronic kidney disease. Plaintiffs have also brought allegations of renal failure being caused by the drugs. To date, over 5,000 PPI cases are under investigation by plaintiff’s counsel, and more could be added to that number as awareness of the link between PPI use and kidney damage continues to increase.

Although the drug class first received FDA approval in 1989, it was not until serious side effects prompted the FDA in 2014 to require all PPIs to place a warning label that identified the connection of the drug to acute interstitial nephritis. The plaintiff’s brief also mentions several studies that have made a connection between PPI use and kidney damage during the past 25 years, including a 1992 study by the University of Arizona Health Sciences Center, a 2006 study conducted at the Yale School of Medicine, and a 2016 study from Johns Hopkins published in the Journal of the American Medical Association (JAMA).

In January, the plaintiffs note that the JPML denied centralization of PPI cases, but say later significant developments “warrant a second look at consolidation.”

The defendants include AstraZeneca Pharmaceuticals LP, Proctor & Gamble Co., McKesson Corp., Takeda Pharmaceuticals USA Inc., Novartis Pharmaceuticals Corp., Pfizer Inc., and Pfizer subsidiary Wyeth.

Need Legal Help Regarding Proton Pump Inhibitor?

The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).

 

Our Proton Pump Inhibitor injury attorneys are here to help you when you need it the most.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Today i just received my acceptance letter from the W.T.C and VCF just wanna say the excellent work of your employee trisha and christina morace did a fairy good job I would love them to represent me anytime Under any situation. A extra special thank you for that for those great employees.
andre facey
7 months ago
5 Star Reviews 150
Took on my case when my original representative became dysfunctional. Accurate, knowledgeable, totally transparent. Excellent commincation, I couldn't have expected more. I highly recommend this firm!
Bob Ballard
4 years ago
5 Star Reviews 150
Positive: Professionalism , Quality , Responsiveness , Value I would recommend this firm to anyone who has a problem similar to mine. They are very professional and friendly. They keep you updated. The paralegals whom I spoke with were great. They took the time to explain anything I did not understand.
mary alston
3 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038